Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Mucosal tolerance has been considered a potentially important pathway for the treatment of autoimmune disease, including human multiple sclerosis and experimental conditions such as experimental autoimmune encephalomyelitis (EAE). There is limited information on the capacity of commensal gut bacteria to induce and maintain peripheral immune tolerance. Inbred SJL and C57BL/6 mice were treated orally with a broad spectrum of antibiotics to reduce gut microflora. Reduction of gut commensal bacteria impaired the development of EAE. Intraperitoneal antibiotic-treated mice showed no significant decline in the gut microflora and developed EAE similar to untreated mice, suggesting that reduction in disease activity was related to alterations in the gut bacterial population. Protection was associated with a reduction of proinflammatory cytokines and increases in IL-10 and IL-13. Adoptive transfer of low numbers of IL-10-producing CD25+CD4+ T cells (>75% FoxP3+) purified from cervical lymph nodes of commensal bacteria reduced mice and in vivo neutralization of CD25+ cells suggested the role of regulatory T cells maintaining peripheral immune homeostasis. Our data demonstrate that antibiotic modification of gut commensal bacteria can modulate peripheral immune tolerance that can protect against EAE. This approach may offer a new therapeutic paradigm in the treatment of multiple sclerosis and perhaps other autoimmune conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“depletion of gut commensal bacteria by antibiotic treatment dampens the progression of experimental autoimmune encephalomyelitis in mice, which is suggested to be mediated by induction of IL-10-producing regulatory T cells.245”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [245]
In the citing paper
“Kasper L.’s group showed that oral but not systemic treatment with a classical pool of broad-spectrum antibiotics (ampicillin, vancomycin, neomycin, and metronidazole) ameliorated the development of acute EAE, in two mouse models (on C57BL/6 and SJL backgrounds) (18).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [18]
In the citing paper
“This effect suggested that the intestinal microbiota was responsible for the disease severity and the modulation of the adaptive immune response during disease development (18).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [18]
In the citing paper
“The better disease outcome upon oral antibiotic treatment was associated with a reduction of pro-inflammatory cytokines and an increase in regulatory cytokines like IL-10 (18).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 3×
“To test whether gut commensal bacteria are involved in the control of inflammatory demyelinating disease, we utilized a broad spectrum of antibiotics (ampicillin, vancomycin, neomycin sulfate, and metronidazole) to reduce the gut commensal bacteria in EAEsusceptible SJL mice (15).”
BackgroundInfluentialEcological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358
Coombes, J. L., Siddiqui, K. R. R., Arancibia-Cárcamo, C. V., Hall, J., Sun, C.-M., Belkaid, Y., & Powrie, F. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070590 · Cited by 2,710
Commensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
Sun, C.-M., Hall, J. A., Blank, R. B., Bouladoux, N., Oukka, M., Mora, J. R., & Belkaid, Y. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070602 · Cited by 1,881
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865 · cited 1×
“The role of IL-17 in the development of EAE has been of interest (34, 35).”
BackgroundIvanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Shevach, E. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.010 · Cited by 1,754
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136 · cited 1×
“Pathogens share the same mucosa and it is the role of the immune system to control concurrently the responses to commensal and pathogenic organisms (3).”
BackgroundBenson, M. J., Pino-Lagos, K., Rosemblatt, M., & Noelle, R. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070719 · Cited by 847
Research works printed but not linked: 1
- 1999, Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response., 6249
Cited by
Items 201–300 of 635
Ekmekçiu, I., von Klitzing, E., Fiebiger, U., Neumann, C., Bächer, P., Scheffold, A., Bereswill, S., & Heimesaat, M. M. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00167 · Cited by 65
Krejner, A., Bruhs, A., Mrowietz, U., Wehkamp, U., Schwarz, T., & Schwarz, A. (2018) · Archives of Dermatological Research · doi:10.1007/s00403-018-1865-1 · Cited by 65
Gut dysbiosis and multiple sclerosis
Noto, D., & Miyake, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108380 · Cited by 65
Moshkelgosha, S., Masetti, G., Berchner‐Pfannschmidt, U., Verhasselt, H. L., Horstmann, M., Díaz‐Cano, S. J., Noble, A., Edelman, B., Covelli, D., Plummer, S. F., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0653-3766 · Cited by 64
Healthy Gut, Healthy Bones: Targeting the Gut Microbiome to Promote Bone Health
Cooney, O. D., Nagareddy, P. R., Murphy, A. J., & Lee, M. K. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.620466 · Cited by 63
“Disease modifying nutricals” for multiple sclerosis
Schmitz, K., Barthelmes, J., Stolz, L., Beyer, S., Diehl, O., & Tegeder, I. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.015 · Cited by 63
Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases
Girolamo, F., Coppola, C., & Ribatti, D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.06.017 · Cited by 63
Gut microbiome and the risk factors in central nervous system autoimmunity
Ochoa-Repáraz, J., & Kasper, L. H. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.024 · Cited by 62
Self-citationCellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges
Khan, Z., Gupta, G. D., & Mehan, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134274 · Cited by 62
Chitrala, K. N., Guan, H., Singh, N. P., Busbee, P. B., Gandy, A. O., Mehrpouya‐Bahrami, P., Ganewatta, M. S., Tang, C., Chatterjee, S., Nagarkatti, P. S., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646792 · Cited by 61
Fleck, A.-K., Hucke, S., Teipel, F., Eschborn, M., Janoschka, C., Liebmann, M., Wami, H. T., Korn, L., Pickert, G., Hartwig, M., et al. (2021) · Brain · doi:10.1093/brain/awab040 · Cited by 60
Ertürk-Hasdemir, D., Ochoa‐Repáraz, J., Kasper, D. L., & Kasper, L. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.662807 · Cited by 59
Self-citationLi, N., Han, X., Ruan, M., Huang, F., Liu, Y., Xu, T., Wang, H., Wu, H., Shi, S., Wang, Y., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2402547 · Cited by 59
Role of the intestinal microbiome in autoimmune diseases and its use in treatments
Marietta, E. V., Horwath, I. E., Balakrishnan, B., & Taneja, V. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.10.005 · Cited by 59
Induction and regulation of pathogenic Th17 cell responses in schistosomiasis
Larkin, B. M., Smith, P. M., Ponichtera, H. E., Shainheit, M. G., Rutitzky, L. I., & Stadecker, M. J. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0341-9 · Cited by 58
Strzępa, A., Majewska‐Szczepanik, M., Lobo, F. M., Li, W., & Szczepanik, M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.11.052 · Cited by 58
Inflammatory Bowel Disease and Neurodegenerative Diseases
Kim, J. S., Chen, M., Wang, H. E., Lu, C., Wang, Y., & Zhang, B. (2023) · Gut and Liver · doi:10.5009/gnl220523 · Cited by 57
Fakhri, S., Yarmohammadi, A., Yarmohammadi, M., Farzaei, M. H., & Echeverría, J. (2021) · Marine Drugs · doi:10.3390/md19030165 · Cited by 57
One more role for the gut: microbiota and blood brain barrier.
Michel, L., & Prat, A. (2016) · PubMed · doi:10.3978/j.issn.2305-5839.2015.10.16 · Cited by 56
Allen, R. G., Lafuse, W. P., Galley, J. D., Ali, M. M., Ahmer, B. M. M., & Bailey, M. T. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.002 · Cited by 55
Aw, W., & Fukuda, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0456-2 · Cited by 57
Effects of the 1975 Japanese diet on the gut microbiota in younger adults
Kushida, M., Sugawara, S., Asano, M., Yamamoto, K., Fukuda, S., & Tsuduki, T. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.10.011 · Cited by 55
Traumatic Spinal Cord Injury and the Gut Microbiota: Current Insights and Future Challenges
Jogia, T., & Ruitenberg, M. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00704 · Cited by 55
Schmidt, E. K. A., Raposo, P. J. F., Espin, A. T., Fenrich, K. K., & Fouad, K. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02123-0 · Cited by 55
A diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity
Alexander, M., Upadhyay, V., Rock, R., Ramirez, L., Trepka, K. R., Puchalska, P., Orellana, D. A., Ang, Q. Y., Whitty, C., Turnbaugh, J. A., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114891 · Cited by 54
Gut microbiome and multiple sclerosis: New insights and perspective
Amini, M. E., Shomali, N., Bakhshi, A., Rezaei, S., Hemmatzadeh, M., Hosseinzadeh, R., Eslami, S., Babaie, F., Aslani, S., Torkamandi, S., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107024 · Cited by 54
Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications
Wang, X., Liang, Z., Wang, S., Ma, D., Zhu, M., & Feng, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210629145351 · Cited by 54
Gut Microbiome and Modulation of CNS Function
Osadchiy, V., Martin, C. R., & Mayer, E. A. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180031 · Cited by 53
“Murine models of various CNS pathologies, including stroke and multiple sclerosis, suggest a role for the gut microbiota in modulating inflammation, immune cell trafficking, and autoimmunity (12, 117, 118, 182, 184).”
Stanisavljević, S., Lukić, J., Soković, S., Mihajlovic, S., Stojković, M. M., Miljković, D., & Golić, N. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02005 · Cited by 53
Autoimmunity, infection and adjuvants
Nr, R. (2010) · Lupus · doi:10.1177/0961203309360670 · Cited by 53
Fleck, A.-K., Schuppan, D., Wiendl, H., & Klotz, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071526 · Cited by 53
Environmental control of autoimmune inflammation in the central nervous system
Rothhammer, V., & Quintana, F. J. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.09.002 · Cited by 52
Yassin, L. K., Skrabulyte-Barbulescu, J., Alshamsi, S. H., Saeed, S., Alkuwaiti, S. H., Almazrouei, S., Alnuaimi, A., BaniYas, S., Aldhaheri, D., Alderei, M., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1667448 · Cited by 53
Mestre, L., Carrillo-Salinas, F. J., Mecha, M., Feliú, A., Espejo, C., Alvarez-Cermeño, J. C., Villar, L. M., & Guaza, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01374 · Cited by 50
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance
Fujiwara, M., Raheja, R., Garo, L. P., Ajay, A. K., Kadowaki-Saga, R., Karandikar, S. H., Gabriely, G., Krishnan, R., Beynon, V., Paul, A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155693 · Cited by 50
Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders
Doussau, F., Dupont, J.-L., Neel, D., Schneider, A., Poulain, B., & Bossu, J. L. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1356285 · Cited by 49
Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration
Stolzer, I., Scherer, E., Süß, P., Rothhammer, V., Winner, B., Neurath, M. F., & Günther, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914925 · Cited by 50
Zonulin as a Biomarker for the Development of Celiac Disease
DaFonte, T. M., Valitutti, F., Kenyon, V., Locascio, J. J., Montuori, M., Francavilla, R., Passaro, T., Crocco, M., Norsa, L., Piemontese, P., et al. (2023) · PEDIATRICS · doi:10.1542/peds.2023-063050 · Cited by 49
Antibiotics and autoimmune and allergy diseases: Causative factor or treatment?
Strzępa, A., Lobo, F. M., Majewska‐Szczepanik, M., & Szczepanik, M. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.021 · Cited by 49
Role of diet in regulating the gut microbiota and multiple sclerosis
Sanchez, J. M. S., DePaula-Silva, A. B., Libbey, J. E., & Fujinami, R. S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108379 · Cited by 49
Blais, L. L., Montgomery, T. L., Amiel, E., Deming, P. B., & Krementsov, D. N. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1943289 · Cited by 49
Multiple Sclerosis and Microbiome
Preiningerova, J. L., Zakostelska, Z. J., Srinivasan, A., Tichá, V., Kovářová, I., Kleinová, P., Tlaskalová-Hogenová, H., & Havrdová, E. (2022) · Biomolecules · doi:10.3390/biom12030433 · Cited by 50
Calvo-Barreiro, L., Eixarch, H., Ponce-Alonso, M., Castillo, M., Lebrón-Galán, R., Mestre, L., Guaza, C., Clemente, D., del Campo, R., Montalban, X., et al. (2020) · Cells · doi:10.3390/cells9040906 · Cited by 48
Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
Wang, X., Li, M., Niu, Y., Zhang, X., Yin, J., Zhao, C.-J., & Wang, R. (2019) · Disease Markers · doi:10.1155/2019/5945721 · Cited by 48
Ellestad, K. K., Thangavelu, G., Ewen, C., Boon, L., & Anderson, C. C. (2014) · European Journal of Immunology · doi:10.1002/eji.201444688 · Cited by 47
Haupeltshofer, S., Leichsenring, T., Berg, S., Pedreiturria, X., Joachim, S. C., Tischoff, I., Otte, J., Bopp, T., Fantini, M. C., Esser, C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905955116 · Cited by 47
Dysbiosis of Gut Microbiome and Its Impact on Epigenetic Regulation
Lee, E. S., Song, E., & Nam, Y. D. (2017) · Journal of Clinical Epigenetics · doi:10.21767/2472-1158.100048 · Cited by 46
Mestre, L., Carrillo-Salinas, F. J., Mecha, M., Feliú, A., & Guaza, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.037 · Cited by 46
Gut Microbiota and Neurologic Diseases and Injuries
Patterson, T. T., & Grandhi, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_6 · Cited by 46
Luminal Conversion and Immunoregulation by Probiotics
Ganesh, B. P., & Versalovic, J. A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00269 · Cited by 46
Mehta, H., Goulet, P.-O., Mashiko, S., Desjardins, J., Pérez, G., Koenig, M., Senécal, J., Constante, M., Santos, M. M., & Sarfati, M. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.06.019 · Cited by 46
Carrillo-Salinas, F. J., Mestre, L., Mecha, M., Feliú, A., del Campo, R., Villarrubia, N., Espejo, C., Montalbán, X., Álvarez-Cermeño, J. C., Villar, L. M., et al. (2017) · Scientific Reports · doi:10.1038/srep44377 · Cited by 45
Intestinal Microbiota in Animal Models of Inflammatory Diseases
Hörmannsperger, G., Schaubeck, M., & Haller, D. (2015) · ILAR Journal · doi:10.1093/ilar/ilv019 · Cited by 45
The role of TLR2 and 4 in Behçet's disease pathogenesis
Seoudi, N., Bergmeier, L. A., Hagi‐Pavli, E., Bibby, D., Curtis, M. A., & Fortune, F. (2013) · Innate Immunity · doi:10.1177/1753425913498042 · Cited by 45
Sodium chloride triggers Th17 mediated autoimmunity
Haase, S., Wilck, N., Kleinewietfeld, M., Müller, D. N., & Linker, R. A. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.016 · Cited by 45
Hosseini, S. A., Nematollahi, S., Husain, D., Banaei-Jahromi, N., Majdinasab, N., & Rahimlou, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.901846 · Cited by 44
The brain’s Geppetto—microbes as puppeteers of neural function and behaviour?
Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0355-x · Cited by 45
Dominant Effects of the Diet on the Microbiome and the Local and Systemic Immune Response in Mice
Ooi, J. H., Waddell, A., Lin, Y., Albert, I. U., Rust, L. T., Holden, V. I., & Cantorna, M. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086366 · Cited by 44
Conde, C., Escribano, B. M., Luque, E., Aguilar-Luque, M., Feijóo, M., Ochoa, J. J., LaTorre, M., Giraldo, A. I., Lillo, R., Agüera, E., et al. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1469281 · Cited by 44
Stanisavljević, S., Čepić, A., Bojić, S., Veljović, K., Mihajlović, S., Đedović, N., Jevtić, B., Momčilović, M., Lazarević, M., Mostarica Stojković, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37505-7 · Cited by 43
Sorini, C., & Falcone, M. (2013) · Europe PMC (PubMed Central) · Cited by 43
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
Bhatia, N. Y., Jalgaonkar, M. P., Hargude, A. B., Sherje, A. P., Oza, M. J., & Doshi, G. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220822172039 · Cited by 43
The sex-specific interaction of the microbiome in neurodegenerative diseases
Cox, L. M., Abou-El-Hassan, H., Maghzi, A. H., Vincentini, J., & Weiner, H. L. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146385 · Cited by 42
Gabbianelli, R., Bordoni, L., Morano, S., Calleja‐Agius, J., & Lalor, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145032 · Cited by 42
Mestre, L., Carrillo-Salinas, F. J., Feliú, A., Mecha, M., Alonso, G., Espejo, C., Calvo‐Barreiro, L., Luque-Garcia, J. L., Estévez, H., Villar, L. M., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1813532 · Cited by 42
Sell, L. B., Ramelow, C. C., Kohl, H. M., Hoffman, K. R., Bains, J. K., Doyle, W. J., Strawn, K. D., Hevrin, T., Kirby, T. O., Gibson, K. M., et al. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108766 · Cited by 42
Self-citationPapel de la microbiota intestinal en el desarrollo de la esclerosis múltiple
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2015) · Neurología · doi:10.1016/j.nrl.2015.07.005 · Cited by 42
Remote control — triggering of brain autoimmune disease in the gut
Wekerle, H., Berer, K., & Krishnamoorthy, G. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.09.009 · Cited by 41
Dietary fatty acids and susceptibility to multiple sclerosis
Haase, S., Haghikia, A., Gold, R., & Linker, R. A. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737372 · Cited by 41
The essential role of t cells in multiple sclerosis: A reappraisal
Constantinescu, C. S., & Gran, B. (2014) · Biomedical Journal · doi:10.4103/2319-4170.128746 · Cited by 41
The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosis
Ochoa‐Repáraz, J., Mágori, K., & Kasper, L. H. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.18 · Cited by 41
Self-citationKobayashi, T., Suzuki, T., Kaji, R., Serata, M., Nagata, T., Ando, M., Iizuka, R., Tsujibe, S., Murakami, J., Kiyoshima-Shibata, J., et al. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2010.617755 · Cited by 40
Nutritional Intervention as an Essential Part of Multiple Sclerosis Treatment?
Penesová, A., Dean, Z., Kollár, B., Havranová, A., Imrich, R., Vlček, M., & Rádiková, Ž. (2018) · Physiological Research · doi:10.33549/physiolres.933694 · Cited by 41
Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis
Atabati, H., Yazdanpanah, E., Mortazavi, H., Bajestani, S. G., Raoofi, A., Esmaeili, S., Khaledi, A., Saburi, E., Afshari, J. T., Sathyapalan, T., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_6 · Cited by 40
The power in numbers: Gut microbiota in Parkinson's disease
Vizcarra, J. A., Wilson, H., & Espay, A. J. (2014) · Movement Disorders · doi:10.1002/mds.26116 · Cited by 41
McMurran, C. E., Guzman de la Fuente, A., Penalva, R., Ben Menachem-Zidon, O., Dombrowski, Y., Falconer, J., Gonzalez, G. A., Zhao, C., Krause, F. N., Young, A. M. H., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905787116 · Cited by 39
“For example, in the immune-driven experimental autoimmune encephalomyelitis model, GF or antibiotics-treated mice are resistant to demyelination (19, 58, 59).”
Libbey, J. E., Sanchez, J. M., Doty, D. J., Sim, J. T., Cusick, M. F., Cox, J. E., Fischer, K. F., Round, J. L., & Fujinami, R. S. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0116 · Cited by 39
Cesarean delivery may increase the risk of multiple sclerosis
Maghzi, A., Etemadifar, M., Heshmat‐Ghahdarijani, K., Nonahal, S., Minagar, A., & Moradi, V. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511424904 · Cited by 39
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
Alkhawajah, M. M., Caminero, A. B., Freeman, H. J., & Oger, J. J.-F. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512461393 · Cited by 39
Cao, G., Wang, Q., Huang, W., Tong, J., Ye, D., He, Y., Liu, Z., Tang, X., Cheng, H., Wen, Q., et al. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.20 · Cited by 39
Emerging Role of Diet and Microbiota Interactions in Neuroinflammation
Janakiraman, M., & Krishnamoorthy, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02067 · Cited by 38
Montgomery, T. L., Peipert, D., & Krementsov, D. N. (2024) · Immunological Reviews · doi:10.1111/imr.13343 · Cited by 38
Tracing environmental markers of autoimmunity: introducing the infectome
Bogdanos, D. P., Smyk, D. S., Invernizzi, P., Rigopoulou, E. I., Blank, M., Sakkas, L. I., Pouria, S., & Shoenfeld, Y. (2013) · Immunologic Research · doi:10.1007/s12026-013-8399-6 · Cited by 38
Antibiotics protect against EAE by increasing regulatory and anti-inflammatory cells
Seifert, H. A., Benedek, G., Nguyen, H., Gerstner, G., Zhang, Y., Kent, G., Vandenbark, A. A., Bernhagen, J., & Offner, H. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0266-7 · Cited by 37
Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential
Lv, R., Liu, B., Jiang, Z., Zhou, R., Liu, X., Lu, T., Bao, Y., Huang, C., Zou, G., Zhang, Z., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156104 · Cited by 37
Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
Taitz, J., Tan, J., Ni, D., Potier‐Villette, C., Grau, G. E., Nanan, R. K. H., & Macia, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1493991 · Cited by 37
Kohl, H. M., Castillo, A., & Ochoa‐Repáraz, J. (2020) · Diseases · doi:10.3390/diseases8030033 · Cited by 37
Self-citationZorea, J., Motro, Y., Mazor, R. D., Carmi, Y. K., Shulman, Z., Mahajna, J. A., Moran‐Gilad, J., & Elkabets, M. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02680-7 · Cited by 36
Lin, C. H., Kadakia, S., & Frieri, M. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.09.011 · Cited by 36
Gut environmental factors and multiple sclerosis
Miyake, S., & Yamamura, T. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.015 · Cited by 36
Stanisavljević, S., Lukić, J., Momčilović, M. B., Miljković, M., Jevtić, B., Kojić, M., Golić, N., Stojković, M. M., & Miljković, D. M. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0159 · Cited by 36
Bellavista, E., Santoro, A., Galimberti, D., Comi, C., Luciani, F., & Mishto, M. (2014) · Autoimmune Diseases · doi:10.1155/2014/739705 · Cited by 35
Environmental factors in the development of multiple sclerosis
Michel, L. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.03.010 · Cited by 36
Li, D., Pan, Y., Xia, X., Liang, J., Liu, F., Dou, H., & Hou, Y. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173421 · Cited by 35
Bello-Medina, P. C., Corona-Cervantes, K., Zavala-Torres, N. G., González, A., Pérez-Morales, M., González-Franco, D. A., Gómez, A., García-Mena, J., Díaz-Cintra, S. Y., & Pacheco‐López, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158209 · Cited by 35
Bouillon, A., Ferreira, M. S. V., Awad, S. A., Richter, J., Hochhaus, A., Kunzmann, V., Dengler, J. B., Janssen, J. J. W. M., Ossenkoppele, G. J., Westerweel, P. E., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018017772 · Cited by 35
Microbial control of regulatory and effector T cell responses in the gut
Hand, T., & Belkaid, Y. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.008 · Cited by 35
Insights into the Mechanisms That May Clarify Obesity as a Risk Factor for Multiple Sclerosis
Huitema, M. J. D., & Schenk, G. J. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0827-5 · Cited by 34
Stanisavljević, S., Dinić, M., Jevtić, B., Nikolovski, N., Momčilović, M. B., Đokić, J., Golić, N., Stojković, M. M., & Miljković, D. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00942 · Cited by 34
Reciprocity in Microbiome and Immune System Interactions and its Implications in Disease and Health
Nikoopour, E., & Singh, B. (2014) · Inflammation & Allergy - Drug Targets · doi:10.2174/1871528113666140330201056 · Cited by 34
Metadata
- Authors
- Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., & Kasper, L. H.
- Affiliations
- Department of Medicine
- Dartmouth College (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 183
- Issue
- 10
- Pages
- 6041-6050
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2112999168
- Cited by
- 590
- References
- 35
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 31 · 2023: 39 · 2022: 46 · 2021: 63 · 2020: 55 · 2019: 37 · 2018: 60 · 2017: 49 · 2016: 35 · 2015: 30 · 2014: 35 · 2013: 20 · 2012: 17
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Multiple Sclerosis Society (CA1027A1/3)
- Teva Pharmaceutical Industries
- Dartmouth College
- Multiple Sclerosis Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- gut commensal bacteria, experimental autoimmune encephalomyelitis, mucosal tolerance, peripheral tolerance, antibiotic-induced dysbiosis, multiple sclerosis, regulatory T cells, Foxp3, IL-10, IL-13, inflammatory cytokines, CD4+CD25+ T cells, adoptive transfer, autoimmune disease therapy
- MeSH terms
- Administration, Oral, Animals, Anti-Bacterial Agents, Bacteria, Encephalomyelitis, Autoimmune, Experimental, Female, Glycoproteins, Intestines, Mice, Inbred C57BL, Peptide Fragments, Cytokines, Interleukin-10, Interleukin-13, Immunity, Mucosal, Myelin Proteolipid Protein, Adoptive Transfer, T-Lymphocytes, Regulatory, Mice, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.